MetaCap

Carlsmed (CARL) vs MiMedx Group (MDXG)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Carlsmed (CARL) has outperformed MiMedx Group (MDXG) over the past year, gaining 39.5% versus a loss of 54.9%. Carlsmed is the larger company by market cap ($477.4 million vs $445.1 million), about 1.1 times the size. MiMedx Group converts more of its revenue into profit, with a net margin of 11.6% versus -58.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CARL+39.47%MDXG-54.88%
+54%-3%-60%
Nov 21, 20251 yearNov 20, 2026
CARL+20.14%MDXG-54.95%
+24%-17%-59%
Jul 21, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CARL versus MDXG key metrics
MetricCARLMDXG
Share price$17.42$3.05
Market cap$477.38M$445.07M
1-day change+1.16%-1.93%
YTD return+41.05%-54.95%
1-year return+39.47%-54.88%
5-year return—-58.62%
Forward P/E—122.00
EPS (TTM)$-1.13$-0.13
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$50.51M$418.63M
Revenue growth (YoY)+85.94%+19.99%
Net income (latest FY)$-29.63M$48.58M
Gross margin75.31%82.56%
Operating margin-60.53%15.26%
Net margin-58.67%11.60%
52-week high$19.15$7.45
52-week low$8.50$3.03
Distance from 52-week high-9.05%-59.06%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+26.29%+129.51%
Average volume112.80K1.39M
Shares outstanding27.40M145.93M
Employees127808
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CARL has outperformed MDXG by 94.4 percentage points over the past year.
  • MiMedx Group is more profitable, keeping 11.6 cents of every revenue dollar as net income versus -58.7 cents for Carlsmed.
  • Carlsmed grew revenue faster in its latest fiscal year (+85.94% vs +19.99%).

About Carlsmed

CARL stock →

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.

Health Care · Medical/Dental Instruments · 127 employees

About MiMedx Group

MDXG stock →

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.

Health Care · Medical/Dental Instruments · 808 employees

CARL vs MDXG FAQ

Which is bigger, Carlsmed or MiMedx Group?

Carlsmed (CARL) is larger, with a market capitalization of $477.38M compared with $445.07M for MiMedx Group (MDXG).

Which stock has performed better over the past year, CARL or MDXG?

CARL returned +39.47% over the past 12 months, compared with -54.88% for MDXG (price return, excluding dividends). Past performance does not predict future results.

Are Carlsmed and MiMedx Group in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons